CCIA
ABMD

Campbell & Co Investment Adviser’s Abiomed Inc ABMD Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-708
Closed -$230K – 881
2021
Q3 		$230K Buy
+708
New +$240K 0.07% 467
2020
Q4 		– Sell
-2,766
Closed -$766K – 606
2020
Q3 		$766K Buy
+2,766
New +$797K 0.57% 22
2019
Q2 		– Sell
-1,079
Closed -$308K – 747
2019
Q1 		$308K Buy
+1,079
New +$359K 0.15% 264
2017
Q2 		– Sell
-1,847
Closed -$231K – 381
2017
Q1 		$231K Buy
+1,847
New +$214K 0.6% 84
2015
Q2 		– Sell
-3,749
Closed -$268K – 262
2015
Q1 		$268K Buy
+3,749
New +$203K 0.17% 163

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Campbell & Co Investment Adviser's ABMD Position: Q4 2021 in Review

Campbell & Co Investment Adviser sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 708 shares — an estimated $230K sold.

Campbell & Co Investment Adviser first reported a position in ABMD in Q1 2015 and held it in 5 quarters. The position peaked at $766K in Q3 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Campbell & Co Investment Adviser reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 708 Abiomed Inc shares in Q4 2021, an estimated $230K.
  • Campbell & Co Investment Adviser first reported a position in Abiomed Inc in Q1 2015 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's Abiomed Inc position peaked at $766K in Q3 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2021, filed 10 Feb 2022.